Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study boosts UAE (uterine artery embolisation) for treating fibroids:

This article was originally published in Clinica

Executive Summary

Data from what is claimed to be the largest prospective study of its kind to assess uterine artery embolisation (UAE) has added to the growing body of evidence supporting the procedure as a treatment for uterine fibroids. UK researchers, from The Royal Surrey County Hospital, Surrey, found that the technique improved menstrual bleeding in 84% of 400 women and menstrual pain in 79%. The findings appear in The British Journal of Obstetrics and Gynaecology (November). However, a separate study, published in another journal, Obstetrics & Gynaecology (November), found that women who undergo UAE put themselves at greater risk of complications should they later become pregnant (see Clinica No 1032, p 25).

Topics

UsernamePublicRestriction

Register

MT069113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel